secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOOKIPA Pharma Inc. (HOOK)
CIK:        0001760542
Form:       8-K
Filed at:   2025-07-18T23:59:59+00:00
Accession:  0001104659-25-069029
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HOOKIPA plans voluntary delisting and deregistration ahead of asset sale to Gilead and dissolution
--------------------------------------------------------------------------------

- Intends to voluntarily delist from Nasdaq; Form 25 expected July 29, delisting effective ~August 8, 2025.
- Will file Form 15 to deregister under Section 12(g) and suspend SEC reporting after delisting.
- Delisting/deregistration tied to pending asset sale to Gilead for HB-400/HB-500 programs and planned dissolution.
- Special meeting of stockholders set for July 29, 2025 to approve asset sale and dissolution.
- Upon dissolution, proceeds from asset sale and other assets to be distributed to stockholders after liabilities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760542/000110465925069029/0001104659-25-069029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760542/000110465925069029/tm2521167d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-069029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer